600866.SH
星湖科技
SSE · Healthcare · Biotechnology · CN
CNY 4.23
−0.47%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 15.6B | 15.9B | 17.3B | 17.4B | 17.5B |
| Cost of Revenue | 13.6B | 13.3B | 14.4B | 14.9B | 14.4B |
| Gross Profit | 2.0B | 2.6B | 3.0B | 2.4B | 3.1B |
| Operating Expenses | |||||
| R&D Expense | 178.7M | 184.1M | 171.9M | 181.6M | 182.6M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 803.8M | 755.2M | 718.6M | 640.5M | 681.2M |
| Selling & Marketing Expense | 317.9M | 319.3M | 366.0M | 321.1M | 266.4M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 1.5B | 1.4B | 1.4B | 1.4B | 1.6B |
| Cost and Expenses | 15.0B | 14.7B | 15.8B | 16.3B | 16.0B |
| Operating Income (EBIT) | 541.9M | 1.2B | 1.2B | 867.4M | 1.4B |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 574.0M | 1.2B | 1.2B | 863.6M | 1.4B |
| Income Tax Expense | 124.8M | 248.2M | 283.3M | 177.9M | 240.6M |
| Bottom Line | |||||
| Net Income | 457.8M | 978.9M | 943.2M | 678.0M | 608.3M |
| Earnings from Cont. Ops | 449.2M | 970.0M | 949.8M | 685.7M | 1.2B |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 457.8M | 978.9M | 943.2M | 678.0M | 608.3M |
| Per Share | |||||
| Basic EPS | CN¥0.28 | CN¥0.59 | CN¥0.57 | CN¥0.41 | CN¥0.51 |
| Diluted EPS | CN¥0.28 | CN¥0.59 | CN¥0.57 | CN¥0.41 | CN¥0.51 |
| Revenue Per Share | CN¥9.38 | CN¥9.57 | CN¥10.43 | CN¥10.46 | CN¥14.72 |
| Shares | |||||
| Basic Shares Outstanding | 1.7B | 1.7B | 1.7B | 1.7B | 1.2B |
| Diluted Shares Outstanding | 1.7B | 1.7B | 1.7B | 1.7B | 1.2B |
| Profitability Metrics | |||||
| EBITDA | — | 2.0B | 2.1B | 1.7B | 2.4B |
| D&A | — | 842.0M | 840.1M | 852.1M | 980.5M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026